Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B

Liver International

Volumn 31, Issue 6, 2011, Pages 824-830

  Alam, Shahinul ^a   Ahmad, Nooruddin ^a   Mustafa, Golam ^a   Shrestha, Ananta ^a   Alam, Akm Khorshed ^a   Khan, Mobin ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

ALT; Chronic hepatitis b; Histological activity

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DNA BLOOD LEVEL; FEMALE; HEPATITIS B; HISTOLOGICAL ACTIVITY INDEX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SINGLE BLIND PROCEDURE;

EID: 79958042869     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02491.x     Document Type: Article

References (31)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
2. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25 (Suppl. 1): 3-8.
3. Yi m Y HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006; 43: S173-81.
4. Mahtab MA, Rahman S, Karim F, et al. Epidemiology of hepatitis B virus in Bangladeshi general population. Hepatobiliary Pancreat Dis Int 2008; 7: 595-600.
5. Alam S, Ahmad N, Mustafa G, Alam K, Khan M. Characteristics of treatment naive chronic hepatitis B in Bangladesh: younger populations are more effected; e antigen negatives are more advanced. Saudi J Gastroenterol 2008; 14: 15-9.
6. Fattovich G, Brollo L, Giustina G, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294-8.
7. Yu MW, Hsu FC, Sheen IS, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997; 145: 1039-47.
8. Weissberg JI, Andress LL, Smith CL, et al. Survival in chronic hepatitis B An analysis of 379 patients. Ann Intern Med 1984; 101: 613-6.
9. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269-76.
10. Sylvan S. WHO spearheads global initiative to eradicate hepatitis B. Lakartidningen 2000; 97: 3738-40.
11. Hadziyannis SJ, Papatheodoridis GV. Hepatitis B e antigen negative chronic hepatitis B: natural history and treatment. Semin Liver Dis 2006; 26: 130-41.
12. Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983-8.
13. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10.
14. Ricci G, De Bac C, Caramia F. Carriers of hepatitis B antigen: an epidemiologic and histologic study. J Infect Dis 1973; 128: 125-8.
15. Tapp E, Jones DM, Hollanders D, et al. Serial liver biopsies in blood donors with persistent HBs antigenaemia. J Clin Pathol 1976; 29: 884-6.
16. Dragosics B, Ferenci P, Hitchman E, et al. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology 1987; 7: 302-6.
17. de Franchis R, D'Arminio A, Vecchi M, et al. Chronic asymptomatic HBsAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV. Gastroenterology 1980; 79: 521-7.
18. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-39.
19. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006; 4: 936-62.
20. Liaw Y-F, Leung N, Kao J-H, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263-83.
21. European Association for the Study of the Liver EASL clinical practice guide lines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-42.
22. Alam S, Azam G, Mustafa G, et al. Pretreatment and on - treatment predictors of viral breakthrough in lamivudine therapy for chronic hepatitis B. Hepatol Int 2008; 2: 494-7.
23. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in symptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
24. Ahmad N, Alam S, Mustafa G, et al. e-Antigen-negative chronic hepatitis B in Bangladesh hepatobiliary. Pancreat Dis Int 2008; 7: 379-82.
25. Croagh CMN, Bell SJ, Slavin J, et al. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis. In HBeAg negative but not HBeAg positive chronic hepatitis B. Liver Int 2010; 30: 1115-22.
26. Puoti C, Magrini A, Stati T, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997; 26: 1393-8.
27. Assy N, Beniashvili Z, Djibre A, et al. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg(-) chronic hepatitis B patients from inactive chronic carriers. World J Gastroenterol 2009; 15: 3025-31.
28. Kumar M, Sarin SK, Hissar S, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-84.
29. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 2007; 47: 760-7.
30. Cooksley WG. Natural history of chronic hepatitis B: extending the REVEAL study. Liver Int 2010; 30: 1085-6.
31. Sarin SK, Kumar M. Should chronic HBV infected patients with normal ALT treated: debate. Hepatol Int 2008; 2: 179-84.